{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:21:30Z","timestamp":1783167690265,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MB036"],"award-info":[{"award-number":["ZR2023MB036"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204288"],"award-info":[{"award-number":["82204288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejps.2026.107573","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:13:05Z","timestamp":1780474385000},"page":"107573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering piroxicam crystals with targeted morphologies and polymorphs using organic additives: A comprehensive study of tablet performance and molecular mechanisms"],"prefix":"10.1016","volume":"223","author":[{"given":"Maoyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-2513","authenticated-orcid":false,"given":"Shuai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107573_bib0006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/pharmaceutics10040171","article-title":"Kinetics of the solution-mediated polymorphic transformation of the novel l-carnitine orotate polymorph, form-I","volume":"10","author":"An","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107573_bib0024","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/cg200492w","article-title":"Solubility advantage of amorphous drugs and pharmaceutical cocrystals","volume":"11","author":"Babu","year":"2011","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107573_bib0023","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/cg050125l","article-title":"Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities","volume":"5","author":"Banerjee","year":"2005","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107573_bib0035","series-title":"Pharmacopoeia of the People's Republic of China 2020 Edition, Four parts","year":"2020"},{"key":"10.1016\/j.ejps.2026.107573_bib0009","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.3390\/molecules201018759","article-title":"Polymorph impact on the bioavailability and stability of poorly soluble drugs","volume":"20","author":"Censi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2026.107573_bib0014","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acs.cgd.5c00146","article-title":"Solvent effects on the crystal morphology of pentaerythritol tetranitrate (Petn)","volume":"25","author":"Davis","year":"2025","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107573_bib0004","first-page":"181","article-title":"Investigation of physicochemical properties and in-vitro in-vivo evaluation of agomelatine polymorphs","volume":"8","author":"Du","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107573_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124969","article-title":"Solution-mediated phase transformation of cocrystals at the solid-liquid interface: relationships between the supersaturation generation rate and transformation pathway","volume":"668","author":"Fan","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2026.107573_bib0032","article-title":"Analysis of the crystalline form of piroxicam and the 1,2-dichloride ethane residue in the p\u2171 crystalline form of piroxicam tablets by Nidrs combined with Gc-Ms","volume":"37","author":"Huang","year":"2017","journal-title":"Chin J. Pharm. Anal."},{"key":"10.1016\/j.ejps.2026.107573_bib0039","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"Vmd: visual Molecular Dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ejps.2026.107573_bib0002","first-page":"163","article-title":"A practical guide to pharmaceutical polymorph screening & selection","volume":"9","author":"Lee","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107573_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124189","article-title":"Accelerated stability modeling of recrystallization from amorphous solid dispersions: a Griseofulvin\/Hpmc-as case study","volume":"657","author":"Leon","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrysgro.2019.06.025","article-title":"Controllable crystallization of Urea crystal face (0 0 1) by Molecular simulation","volume":"524","author":"Li","year":"2019","journal-title":"J. Cryst. Growth"},{"key":"10.1016\/j.ejps.2026.107573_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125006","article-title":"Enhanced transdermal delivery of insulin by choline-based ionic liquids","volume":"667","author":"Li","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0013","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/molecules29020367","article-title":"The effect of solvents on the crystal morphology of isosorbide mononitrate and its molecular mechanisms","volume":"29","author":"Li","year":"2024","journal-title":"Molecules."},{"key":"10.1016\/j.ejps.2026.107573_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124709","article-title":"Preparation of tenofovir amibufenamide fumarate spherical particles to improve tableting performance and sticking propensity by designing a spherical crystallization process","volume":"665","author":"Liu","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jct.2025.107513","article-title":"Equilibrium solubilities, model analysis, solvent effect, and thermodynamic properties of 5-amino-1,3,4-thiadiazole-2-thiol in thirteen organic mono-solvents","volume":"208","author":"Liu","year":"2025","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.ejps.2026.107573_bib0038","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2026.107573_bib0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2478\/v10007-011-0037-z","article-title":"Crystal modifications and dissolution rate of Piroxicam","volume":"61","author":"Lyn","year":"2011","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0001","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2019.05.071","article-title":"Identification of novel adefovir dipivoxil-saccharin cocrystal polymorphs and their thermodynamic polymorphic transformations","volume":"566","author":"Ma","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0037","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1002\/wcms.1326","article-title":"Molecular electrostatic potentials and noncovalent interactions","volume":"7","author":"Murray","year":"2017","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107573_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.127566","article-title":"Modeling of pharmaceutical filtration and Continuous integrated crystallization-filtration processes","volume":"413","author":"Nagy","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejps.2026.107573_bib0028","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejpb.2014.11.027","article-title":"Solid State transformations in consequence of electrospraying \u2013 a novel polymorphic form of piroxicam","volume":"89","author":"Nystr\u00f6m","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107198","article-title":"The influence of solvent composition and process parameters on the particle properties of phytosterols in batch cooling crystallization","volume":"212","author":"\u00d6versti","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107573_bib0031","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/cryst11121552","article-title":"Solubility and crystallization of piroxicam from different solvents in evaporative and cooling crystallization","volume":"11","author":"Ostergaard","year":"2021","journal-title":"Crystals"},{"key":"10.1016\/j.ejps.2026.107573_bib0033","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2012.04.042","article-title":"Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms","volume":"431","author":"Paaver","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0027","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/cg049876y","article-title":"Polymorphism in Piroxicam","volume":"4","author":"Sheth","year":"2004","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107573_bib0019","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1039\/C5CE01878A","article-title":"Tailoring crystal shape and polymorphism using combinations of solvents and a structurally related additive","volume":"17","author":"Simone","year":"2015","journal-title":"Cryst. Eng. Comm."},{"key":"10.1016\/j.ejps.2026.107573_bib0036","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1107\/S1600576721002910","article-title":"Crystalexplorer: a program for Hirshfeld Surface Analysis, visualization and quantitative analysis of molecular crystals","volume":"54","author":"Spackman","year":"2021","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2026.107573_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125994","article-title":"Complex investigation of the effect mechanism of polyvinylpyrrolidone in the additive-assisted crystallization of famotidine","volume":"682","author":"Stoff\u00e1n","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0003","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11095-025-03997-y","article-title":"Polymorphism control of carbamazepine based on deep eutectic solvents","volume":"43","author":"Sun","year":"2026","journal-title":"Pharm. Res"},{"key":"10.1016\/j.ejps.2026.107573_bib0005","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/pharmaceutics15061747","article-title":"Polymorphism of Carbamazepine Pharmaceutical Cocrystal: structural analysis and solubility performance","volume":"15","author":"Surov","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107573_bib0026","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1039\/C5CE00050E","article-title":"Crystallization and disorder of the polytypic \u03911 and \u03912 polymorphs of piroxicam","volume":"17","author":"Upadhyay","year":"2015","journal-title":"Cryst. Eng. Comm."},{"key":"10.1016\/j.ejps.2026.107573_bib0016","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1021\/jacs.6b03604","article-title":"Advancing drug formulation additives toward precision additives with release mediating peptide interlayer","volume":"138","author":"Wieczorek","year":"2016","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.ejps.2026.107573_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev"},{"key":"10.1016\/j.ejps.2026.107573_bib0030","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1021\/acs.cgd.4c00951","article-title":"Polyethylene glycol-assisted melt crystallization of two new piroxicam polymorphs revealed by 3d electron diffraction","volume":"24","author":"Xu","year":"2024","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107573_bib0029","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/acs.cgd.0c01165","article-title":"Polymorphism of Piroxicam: new polymorphs by melt crystallization and crystal structure prediction","volume":"20","author":"Yao","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107573_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/crat.202100025","article-title":"Optimization of the crystallization process of bis(2-Hydroxyethyl) terephthalate","volume":"56","author":"Yuan","year":"2021","journal-title":"Cryst. Res. Technol."},{"key":"10.1016\/j.ejps.2026.107573_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121235","article-title":"Crystallization kinetics and molecular dynamics of binary coamorphous systems of Nimesulide and Profen Analogs","volume":"610","author":"Zhang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107573_bib0018","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1021\/acs.iecr.3c04468","article-title":"Modulation of adn crystal surface properties by additives","volume":"63","author":"Zheng","year":"2024","journal-title":"Ind. Eng. Chem. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:05:58Z","timestamp":1783166758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S0928098726001478"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107573","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering piroxicam crystals with targeted morphologies and polymorphs using organic additives: A comprehensive study of tablet performance and molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107573"}}